EVIO, Inc. (OTCPK:EVIO) announced a private placement on a best efforts basis of units at a price of $0.40 per unit on April 10, 2019. Each unit will consist of one common stock and a share purchase warrant, where each warrant shall entitle the holder thereof to purchase one additional common share of the company at an exercise price of $0.65 per warrant share for a period of 24 months after the closing of the transaction.
On the same date, the company issued 1,465,000 units at a price of $0.40 per unit for gross proceeds of $586,000 in its first tranche closing.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.
EVIO, INC. 
